Thyroid cancer: open trials in Singapore

• NCT07521670

  Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

  Trial Treatment · Phase 2 · National Cancer Centre, Singapore

  Tan Tock Seng Hospital, Singapore · National Cancer Centre Singapore, Singapore

  Registry updated 2026-07-15

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  National University Hospital, Singapore · National Cancer Center Singapore, Singapore

  Registry updated 2026-05-27

• NCT06923826

  Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)

  Trial Treatment · Phase 2 · National University Hospital, Singapore

  National University Cancer Institute, Singapore, Singapore

  Registry updated 2025-07-25

• NCT03175224

  APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  Trial Treatment · Phase 2 · Apollomics Inc.

  National Cancer Centre Singapore, Singapore

  Registry updated 2025-06-27

All Thyroid cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error